{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:14:03Z","timestamp":1792811643991,"version":"4.5.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Prion diseases are rapidly progressive neurodegenerative conditions that can be difficult to diagnose and are transmissible under specific circumstances. The authors will provide background regarding prion disease and focus on diagnostic tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Prion disease is caused by misfolded prion protein. The three possible causes of prion disease include sporadic (85%), genetic (10\u201315%), and acquired (&lt;1%). Acquired prion diseases include kuru, iatrogenic, and variant Creutzfeldt\u2013Jakob disease. Prion diseases differ in their clinical manifestation, neuropathology, and diagnostic test results. A variety of recent diagnostic tools have evolved that allow more reliable antemortem diagnosis of prion disease such as brain MRI and cerebrospinal fluid real-time quaking-induced conversion. Special infectivity guidelines must be followed when dealing with central nervous system tissue, but only standard precautions are needed for routine clinical care of patients with prion disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>The only way to definitely diagnose prion disease and determine its type is via neuropathologic examination. However, brain MRI and cerebrospinal fluid real-time quaking-induced conversion have drastically increased diagnostic accuracy and are important tests to use when evaluating patients with suspected prion disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/qco.0000000000000552","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T21:46:19Z","timestamp":1555710379000},"page":"272-276","source":"Crossref","is-referenced-by-count":30,"title":["Human prion diseases"],"prefix":"10.1097","volume":"32","author":[{"given":"Han","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, University Hospitals Cleveland Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Rhoads","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Prion Disease Pathology Surveillance Center"},{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"Appleby","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospitals Cleveland Medical Center"},{"name":"Department of Pathology, National Prion Disease Pathology Surveillance Center"},{"name":"Department of Pathology"},{"name":"Department Psychiatry, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230925","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2990.2012.01265.x","article-title":"Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain","volume":"38","author":"Head","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R3-20230925","doi-asserted-by":"crossref","first-page":"e8521","DOI":"10.1371\/journal.pone.0008521","article-title":"Human prion diseases in the United States","volume":"5","author":"Holman","year":"2010","journal-title":"PLoS One"},{"key":"R4-20230925","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"key":"R5-20230925","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-444-63945-5.00010-6","article-title":"Variably protease-sensitive prionopathy","volume":"153","author":"Notari","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"R6-20230925","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(03)00323-5","article-title":"Familial and sporadic fatal insomnia","volume":"2","author":"Montagna","year":"2003","journal-title":"Lancet Neurol"},{"key":"R7-20230925","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1098\/rstb.2008.0071","article-title":"Review. The epidemiology of kuru: monitoring the epidemic from its peak to its end","volume":"363","author":"Alpers","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R8-20230925","first-page":"4028","article-title":"Prions mediated neurodegenerative disorders","volume":"19","author":"Huang","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R9-20230925","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1098\/rstb.2008.0069","article-title":"Review. The origin of the prion agent of kuru: molecular and biological strain typing","volume":"363","author":"Wadsworth","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R10-20230925","first-page":"1059","article-title":"Prions and prion diseases: fundamentals and mechanistic details","volume":"17","author":"Ryou","year":"2007","journal-title":"J Microbiol Biotechnol"},{"key":"R11-20230925","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/vox.12631","article-title":"Creutzfeldt-Jakob disease and blood transfusion safety","volume":"113","author":"Seed","year":"2018","journal-title":"Vox Sang"},{"key":"R12-20230925","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/B978-0-444-63945-5.00012-X","article-title":"Iatrogenic Creutzfeldt-Jakob disease","volume":"153","author":"Kobayashi","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"R13-20230925","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.12688\/f1000research.12681.1","article-title":"Creutzfeldt-Jakob disease: recent developments","volume":"6","author":"Mackenzie","year":"2017","journal-title":"F1000Res"},{"key":"R14-20230925","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"R15-20230925","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24833","article-title":"Diagnostic and prognostic value of human prion detection in cerebrospinal fluid","volume":"81","author":"Foutz","year":"2017","journal-title":"Ann Neurol"},{"key":"R16-20230925","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0b013e3181eb5889","article-title":"Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion","volume":"75","author":"Schuette","year":"2010","journal-title":"Neurology"},{"key":"R17-20230925","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jalz.2016.09.013","article-title":"Evaluation of alpha-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases","volume":"13","author":"Llorens","year":"2017","journal-title":"Alzheimers Dement"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00001432-201906000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:37:46Z","timestamp":1695620266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001432-201906000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0000000000000552","relation":{},"ISSN":["0951-7375","1473-6527"],"issn-type":[{"value":"0951-7375","type":"print"},{"value":"1473-6527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}